Z. Yetim, S. Yakut, and E. Taşkın, “Nicotinamide Riboside, an NAD precursor and supplement, reduces liver damage caused by sepsis”, Rev. Cient. FCV-LUZ, vol. 36, no. 2, p. 7, Feb. 2026.